Tag Archives: FTC

Is the End Near for Pharmaceutical Pay-for-Delay Deals?

CHELSEA OLIVERA—The legal and policy momentum to curb pharmaceutical pay-for-delay deals is ramping up. On September 22, 2021, Humana and Centene, two health insurance companies, individually filed lawsuits in the U.S. District Court of New Jersey against Merck, a pharmaceutical manufacturer. The health insurance companies alleged that Merck engaged in anticompetitive “pay-for-delay” practices that caused […]